Security Check
Dr. Rong-Xin Zhang

Dr. Rong-Xin Zhang, MD, Ph.D.

Senior Consultant
Code: 110440000702788
Hem-Onc (Hematological Oncology) ML (Malignant Lymphoma) MM (Multiple Myeloma) CAR-T (Chimeric Antigen Receptor T-cell Therapy) CIT (Cellular Immunotherapy)
Experience20+ years
LanguagesEnglish | 中文
Typical turnaround3–5 business days
Second-opinion formatWritten review

Overview

Prof. Rong-Xin Zhang is a Chief Physician, Associate Professor, PhD Supervisor, and MD. He is a senior specialist in the Department of Lymphoma at Sun Yat-sen University Cancer Center (SYSUCC). A renowned national expert in hematological oncology, he possesses profound expertise in chemotherapy, targeted therapy, and cellular immunotherapy for malignant lymphoma and multiple myeloma.

Board Certification
Colorectal Surgery
Clinical Focus
Hem-Onc (Hematological Oncology) | CAR-T Specialist (Cellular Immunotherapy) | MM-WCM (Multiple Myeloma Whole-Course Management) | L-IMT (Individualized Lymphoma Multimodal Therapy) | TR-Hem (Translational Research in Hematology)
Approach
Guideline-driven + personalized
Best for
New diagnosis · Recurrence · Complex decisions
Clinical focus & conditions

1.Lymphoma Excellence
Comprehensive management of Hodgkin and Non-Hodgkin Lymphoma.
Subtype-specific therapy for DLBCL, Follicular, and NK/T-cell Lymphomas.
2.Plasma Cell Disorders
Precision treatment and long-term care for Multiple Myeloma (MM).
Specialized management of Waldenström Macroglobulinemia (WM).
3.Other Hematological Malignancies
Advanced clinical interventions for a wide spectrum of Malignant Blood Disorders.

Education & training

MD,Ph.D. — Sun Yat-sen University of Medical Sciences
Training — Dana-Farber Cancer Institute, Harvard Medical School (USA)

Hospital affiliations

Sun Yat-sen University Cancer Center

Honors & Research

Honors:
Awarded "Excellent Young and Middle-aged Backbone Physician" and "Outstanding Teaching Award" by SYSUCC.
Academic Affiliations:
Member of the Anti-Lymphoma Alliance of the CSCO; Member of the Hematological Oncology Committee of the Guangdong Anti-Cancer Association.
Research:
PI for multiple National Natural Science Foundation and provincial research projects. Published over 30 SCI papers in authoritative journals such as JCO, Blood, and Nature Communications, focusing on the lymphoma microenvironment and mechanisms of immune resistance.

Is my case a fit for a second opinion?

A second opinion is often helpful if you have a new diagnosis multiple treatment options discordant pathology or imaging results  progression/recurrence or you want confirmation before starting therapy.
•Good fit: complex decisions uncertainty multiple lines of therapy clinical trial questions.
•Not a fit: emergencies (e.g. severe symptoms acute complications). Seek urgent local care.

Important note

This page is for educational and second-opinion purposes. It is not a substitute for emergency care or an in-person exam. If you have urgent symptoms, contact local emergency services.